AhmedGalalMD

Hematology • Durham, NC

Hematologic Oncology, Myeloproliferative Disorder Hematology-Oncology

Physician

Join to view full profile

Dr. Galal is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Galal's full profile

Already have an account?

Office
201 Trent Dr
Durham, NC 27710
Phone+1 919-684-2255

Education & Training

Ain Shams University Faculty of MedicineClass of 1985

Certifications & Licensure

NJ State Medical License 2024 - 2025
NC State Medical License 2017 - 2024
SD State Medical License Active through 2018

Clinical Trials

A Study of TAK-007 in Adults With Relapsed or Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL) Start of enrollment: 2021 Nov 12
Active, not recruiting
Phase 2
Roles: Principal Investigator
DALY II USA/ MB-CART2019.1 for DLBCL Start of enrollment: 2021 May 25
Recruiting
Phase 2
Roles: Contact

Publications & Presentations

PubMed

7 citations
Microtransplantation in older patients with AML: A pilot study of safety, efficacy and immunologic effects.
Anthony D. Sung, Shekeab Jauhari, Sharareh Siamakpour-Reihani, Arati V. Rao, Janet Staats
American Journal of Hematology. 2020-03-12
2 citations
Finding the right BCR-ABL1 tyrosine kinase inhibitor: a case report of successful treatment of a patient with chronic myeloid leukemia and a V299L mutation using nilot...
Radowan Elnair, Ahmed Galal
BMC Cancer. 2018-11-12
1 citations
Can Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Predict Chimeric Antigen Receptor T Cell Adverse Effects?
Jie Wang, Ahmed Galal
Biology of Blood and Marrow Transplantation. 2019-06-01

Press Mentions

Leukemia Cure We’re Waiting for? Patient Cancer-Free for 11 Years After Innovative TreatmentJune 11th, 2022
Leukemia Cure? Patient Still Cancer-Free 11 Years After Innovative TreatmentJune 9th, 2022
The World Needs a Breakthrough YearJune 7th, 2021